COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology
- PMID: 34190413
- PMCID: PMC8435247
- DOI: 10.1002/ueg2.12115
COVID-19 in gastroenterology: Where are we now? Current evidence on the impact of COVID-19 in gastroenterology
Abstract
Background: The COVID-19 pandemic has created unprecedented challenges in all fields of society with social, economic, and health-related consequences worldwide. In this context, gastroenterology patients and healthcare systems and professionals have seen their routines changed and were forced to adapt, adopting measures to minimize the risk of infection while guaranteeing continuous medical care to chronic patients.
Objective: At this point, it is important to evaluate the impact of the pandemic on this field to further improve the quality of the services provided in this context.
Methods/results/conclusion: We performed a literature review that summarizes the main aspects to consider in gastroenterology, during the pandemic crisis, and includes a deep discussion on the main changes affecting gastroenterology patients and healthcare systems, anticipating the pandemic recovery scenario with future practices and policies.
Keywords: COVID-19; SARS-CoV-2; endoscopy; gastroenterology; inflammatory bowel disease; vaccination.
© 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
Conflict of interest statement
IR‐L has received financial support for traveling and educational activities from or has served as an advisory board member for MSD, Pfizer, Abbvie, Takeda, Janssen, Tillotts Pharma, Shire Pharmaceuticals, Roche, Celltrion, Faes Farma, Ferring, Dr. Falk Pharma, Otsuka Pharmaceutical, and Adacyte. Financial support for research from Tillotts Pharma.
Figures



Comment in
-
COVID-19 in gastroenterology and hepatology: Where will we be?United European Gastroenterol J. 2021 Sep;9(7):743-744. doi: 10.1002/ueg2.12121. Epub 2021 Jul 14. United European Gastroenterol J. 2021. PMID: 34260827 Free PMC article. No abstract available.
Similar articles
-
How to manage inflammatory bowel disease during the COVID-19 pandemic: A guide for the practicing clinician.World J Gastroenterol. 2021 Mar 21;27(11):1022-1042. doi: 10.3748/wjg.v27.i11.1022. World J Gastroenterol. 2021. PMID: 33776370 Free PMC article. Review.
-
Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.Ital J Pediatr. 2023 Jan 26;49(1):15. doi: 10.1186/s13052-023-01418-7. Ital J Pediatr. 2023. PMID: 36698148 Free PMC article. Review.
-
COVID-19 and the digestive system: protection and management during the SARS-CoV-2 pandemic.Rev Esp Enferm Dig. 2020 May;112(5):389-396. doi: 10.17235/reed.2020.7128/2020. Rev Esp Enferm Dig. 2020. PMID: 32338017 Review.
-
Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.Dig Dis Sci. 2021 Apr;66(4):945-953. doi: 10.1007/s10620-021-06874-x. Epub 2021 Mar 3. Dig Dis Sci. 2021. PMID: 33655456 Free PMC article. Review.
-
Correct use of telemedicine in gastroenterology, hepatology, and endoscopy during and after the COVID-19 pandemic: Recommendations from the Italian association of hospital gastroenterologists and endoscopists (AIGO).Dig Liver Dis. 2021 Oct;53(10):1221-1227. doi: 10.1016/j.dld.2021.06.032. Epub 2021 Jul 24. Dig Liver Dis. 2021. PMID: 34312103
Cited by
-
Guidelines, top-notch science & social media-Jump on the bandwagon.United European Gastroenterol J. 2022 Feb;10(1):12-14. doi: 10.1002/ueg2.12203. Epub 2022 Jan 28. United European Gastroenterol J. 2022. PMID: 35088535 Free PMC article. No abstract available.
-
Reducing bureaucracy in clinical trials.United European Gastroenterol J. 2022 Nov;10(9):1029-1030. doi: 10.1002/ueg2.12320. Epub 2022 Oct 12. United European Gastroenterol J. 2022. PMID: 36225092 Free PMC article. No abstract available.
-
Investigating the association between the COVID-19 vaccination and incident gastrointestinal symptomology: A comprehensive dataset.Data Brief. 2023 Jun;48:109287. doi: 10.1016/j.dib.2023.109287. Epub 2023 Jun 1. Data Brief. 2023. PMID: 37287691 Free PMC article.
-
UEG onwards & upwards: A president's perspective.United European Gastroenterol J. 2024 Feb;12(1):155-156. doi: 10.1002/ueg2.12517. Epub 2024 Jan 5. United European Gastroenterol J. 2024. PMID: 38180385 Free PMC article. No abstract available.
-
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
References
-
- World Health Organization. COVID‐19 weekly epidemiological update on COVID‐19 ‐ 20 April 2021. 2021. https://www.who.int/publications/m/item/weekly‐epidemiological‐update‐on...
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous